FDA Clears Eloxx's Exaluren for Phase 2 Trial
The FDA cleared Eloxx Pharmaceuticals' Exaluren for a Phase 2 trial in ADPKD.
Related stories
CCPA Fines Just Dial Rs.10 Lakh Over Ammonium Nitrate Listings
India’s consumer protection authority fined Just Dial for listing sellers of regulated ammonium nitrate without adequate disclosures on licensing, buyer eligibility and traceabilit
M impact | REGULATION | Oct 29, 2026, 02:54 PM UTC
South Korean Court Rejects Tesla FSD Refund Complaint
A Seoul district court rejected a complaint by 88 Tesla owners seeking refunds for Full Self-Driving software. The court found Tesla was not honest in saying its vehicles would be
L impact | REGULATION | Oct 29, 2026, 02:51 PM UTC
Swedish Parliament to Vote on Centre Party Leader as Prime Minister
Sweden's parliament is set to vote on the Centre Party leader for prime minister despite a political gridlock.
L impact | REGULATION | Oct 29, 2026, 02:40 PM UTC
Meta loses appeal over French regulator’s interim measure
Meta lost its appeal against an interim measure ordered by a French regulator.
M impact | REGULATION | Oct 29, 2026, 02:39 PM UTC
FERC genehmigt Kapazitätserhöhung für Rio Grande LNG
NextDecade steigt nach der FERC-Genehmigung und einem ausgewiesenen Quartalsgewinn.
M impact | REGULATION | Oct 29, 2026, 02:37 PM UTC
Argentina Removes Federal Judge Gastón Salmain; He Will Be Placed Under House Arrest
Argentina’s judicial disciplinary tribunal removed federal judge Gastón Salmain, who will be placed under house arrest.
M impact | REGULATION | Oct 29, 2026, 02:36 PM UTC